Recent Quotes

My Watchlist

Indicators

Markets:

Overview

News

Currencies

International

Treasuries

Bicara Therapeutics Inc. - Common Stock (NQ:BCAX)

18.56 UNCHANGED

Streaming Delayed Price Updated: 1:00 PM EST, Nov 28, 2025 Add to My Watchlist

Price and Volume

Detailed Quote

Volume	237
Open	18.56
Bid (Size)	17.99 (100)
Ask (Size)	19.00 (100)
Prev. Close	18.56
Today's Range	18.56 - 18.56
52wk Range	7.800 - 22.68
Shares Outstanding	N/A
Dividend Yield	N/A

Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News

Bicara Therapeutics Announces Publication of an Abstract with Preliminary Phase 1b Expansion Cohort Data Evaluating 750mg of Ficerafusp Alfa Weekly Plus Pembrolizumab in 1L HPV-negative R/M HNSCC at ESMO Asia 2025

Today 7:00 EST

From Bicara Therapeutics Inc.

Via GlobeNewswire

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

November 20, 2025

Via Investor Brand Network

Performance

YTD	+9.7%	+9.7%
1 Month	+14.2%	+14.2%
3 Month	+56.0%	+56.0%
6 Month	+87.5%	+87.5%
1 Year	-7.2%	-7.2%

More News

Bicara Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

November 10, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Remeasuring Biotech Pipelines: The Valuation Signal Investors Have Been Waiting For

November 20, 2025

From BioMedWire

Via GlobeNewswire

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

October 27, 2025

Via Investor Brand Network

Nanomedicine Breakthrough Technology Redefining Drug Delivery, Bioavailability in Oncology

October 27, 2025

Via FinancialNewsMedia

These stocks that are showing activity before the opening bell on Monday. ↗

October 13, 2025

Via Chartmill

Bicara Therapeutics Announces Ficerafusp Alfa Granted Breakthrough Therapy Designation by U.S. FDA for 1L HPV-Negative R/M HNSCC

October 13, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

4 Biotech Stocks Seeing Explosive Momentum Gains ↗

October 07, 2025

Via Benzinga

Bicara Therapeutics to Participate in Upcoming Investor Conferences

August 27, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Reports Second Quarter 2025 Financial Results and Provides Business Update

August 12, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Relay Therapeutics Appoints Claire Mazumdar, Ph.D., to Board of Directors

June 11, 2025

From Relay Therapeutics, Inc.

Via GlobeNewswire

12 Health Care Stocks Moving In Wednesday's After-Market Session ↗

June 04, 2025

Via Benzinga

Bicara Therapeutics to Present at the Goldman Sachs 46th Annual Global Healthcare Conference

June 03, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Demonstrates Deep and Durable Responses with Ficerafusp Alfa Plus Pembrolizumab in 1L HPV-Negative R/M HNSCC at ASCO 2025

June 01, 2025

From Bicara Therapeutics Inc.

Via GlobeNewswire

Bicara Therapeutics Shares Sink Over 43% On Mixed Phase 1/1b Trial Results: What's Going On? ↗

May 23, 2025

Via Benzinga

Let's have a look at the top gainers and losers one hour before the close of the markets of today's session. ↗

May 23, 2025

Via Chartmill

12 Health Care Stocks Moving In Friday's Intraday Session ↗

May 23, 2025

Via Benzinga

Let's take a look at the stocks that are in motion in today's session. ↗

May 23, 2025

Via Chartmill

Gold Gains Over 1%; Ross Stores Shares Dip After Pulling Fiscal 2026 Outlook ↗

May 23, 2025

Via Benzinga

There are notable gap-ups and gap-downs in today's session. ↗

May 23, 2025

Via Chartmill

Nasdaq Down Over 1%; Workday Shares Tumble After Q1 Results ↗

May 23, 2025

Via Benzinga

Merus Skyrockets On 'Unprecedented' Cancer Results, Slamming Bicara Therapeutics ↗

May 23, 2025

Via Investor's Business Daily

Ross Stores, Deckers Outdoor, Xerox Holdings And Other Big Stocks Moving Lower In Friday's Pre-Market Session ↗

May 23, 2025

Via Benzinga

Discover the top movers in Friday's pre-market session. ↗

May 23, 2025

Via Chartmill

Frequently Asked Questions

Is Bicara Therapeutics Inc. - Common Stock publicly traded?

Yes, Bicara Therapeutics Inc. - Common Stock is publicly traded.

What exchange does Bicara Therapeutics Inc. - Common Stock trade on?

Bicara Therapeutics Inc. - Common Stock trades on the Nasdaq Stock Market

What is the ticker symbol for Bicara Therapeutics Inc. - Common Stock?

The ticker symbol for Bicara Therapeutics Inc. - Common Stock is BCAX on the Nasdaq Stock Market

What is the current price of Bicara Therapeutics Inc. - Common Stock?

The current price of Bicara Therapeutics Inc. - Common Stock is 18.56

When was Bicara Therapeutics Inc. - Common Stock last traded?

The last trade of Bicara Therapeutics Inc. - Common Stock was at 11/28/25 01:00 PM ET

Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.